Log in with your email address username.


Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

[Comment] A new standard for malignant pleural mesothelioma

Mesothelioma is an asbestos-related malignancy that begins in the pleural lining of the lung, pericardium, peritoneum, or testes. Early-stage pleural mesothelioma can be resected, but almost always recurs. Many patients are diagnosed at an advanced stage of disease, at which point surgery has no role. Since 2003, the standard treatment for unresectable disease has been combination chemotherapy with cisplatin and pemetrexed.1 Despite many attempts, until now, no regimen has further improved survival.